In addition, LCN2 over-expression has been observed in carcinoma of the esophagus, breast, and ovary [4,9,10,11,12], and is an independent predictor of overall survival of breast and ovarian cancer [8,12]. Here, LCN2 is linked to ovarian carcinoma.